Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Journal of Chemical Information and Modeling|October 2, 2009
Enhanced SAR maps: expanding the data rendering capabilities of a popular medicinal chemistry toolJeremy Kolpak, Peter J Connolly, Victor S Lobanov, et al.Biochemistry|December 10, 2003
Molecular dynamics of the long neurotoxin LSIIIPeter J Connolly, Alan S Stern, Christopher J Turner, et al.Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Synthesis and evaluation of N-acyl sulfonamides as potential prodrugs of cyclin-dependent kinase inhibitor JNJ-7706621Shenlin Huang, Peter J Connolly, Ronghui Lin, et al.Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitorsShenlin Huang, Ronghua Li, Peter J Connolly, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
4-aminopyrimidine-5-carbaldehyde oximes as potent VEGFR-2 inhibitors. Part IIShenlin Huang, Ronghua Li, Kenneth R LaMontagne, et al.Protein Science : a Publication of the Protein Society|August 3, 2006
Fundamental processes of protein folding: measuring the energetic balance between helix formation and hydrophobic interactionsWujing Xian, Peter J Connolly, Marcela Oslin, et al.Journal of Medicinal Chemistry|October 26, 2007
SAR maps: a new SAR visualization technique for medicinal chemistsDimitris K Agrafiotis, Maxim Shemanarev, Peter J Connolly, et al.Bioorganic & Medicinal Chemistry Letters|May 23, 2007
(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS)George Chiu, Shengjian Li, Peter J Connolly, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2007
(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS)George Chiu, Shengjian Li, Peter J Connolly, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2007
(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS)George Chiu, Shengjian Li, Peter J Connolly, et al.Pageof 6